(119) demonstrated that elevated TILs density in highly proliferative Luminal B, HER2-enriched and basal-like subtypes correlates with enhanced anti-tumor immunity, showing strong prognostic value in some patients. This evidence concerns the gene ERBB2 and neoplasm.